Suppr超能文献

经肠道淋巴途径的自微乳药物传递系统:药物靶向的一种有前途的方法。

Self-micro Emulsifying Drug Delivery via Intestinal Lymphatics: A Lucrative Approach to Drug Targeting.

机构信息

Department of Pharmaceutics, Krupanidhi College of Pharmacy, Rajiv Gandhi University of Health Sciences, Bangalore, Karnataka, India.

出版信息

Pharm Nanotechnol. 2023 Jun 6;11(3):238-264. doi: 10.2174/2211738511666230112123235.

Abstract

The intestinal lymphatics are considered one of the most specialized pathways, which promote the absorption of various agents such as vitamins, lipids, xenobiotics, and lipophilic substances. The intestinal lymphatics have provided various advantages like bypassing first-pass effects, and improved bioavailability. The oral delivery of poor hydrophilic drugs can be improved by employing a lipid-based formulation strategy. Self-micro emulsifying drug delivery systems (SMEDDS) are one of the vivacious strategies based on lipid-based drug delivery that have shown their effects by improving the solubility and bioavailability of the therapeutic agents. This review is an insight into the functions, targets, mechanisms, and carriers involved in intestinal lymphatics. Also, the review illustrates the types, formulation requirements, and mechanism of action of SMEDDS in detail. In addition, it describes the targeting, types, physicochemical properties, biological barriers, and benefits of lymphatic targeting in therapy. Finally, the marketed formulations and future aspects of SMEDDS formulations are addressed.

摘要

肠淋巴管被认为是最具专业性的途径之一,它促进了各种物质的吸收,如维生素、脂质、外源性物质和脂溶性物质。肠淋巴管具有许多优势,如绕过首过效应,提高生物利用度。采用基于脂质的制剂策略可以改善亲水性差的药物的口服递送。自微乳药物传递系统(SMEDDS)是基于脂质的药物传递的充满活力的策略之一,它通过提高治疗剂的溶解度和生物利用度来显示其效果。本文综述了肠淋巴管的功能、靶点、机制和载体。此外,还详细说明了 SMEDDS 的类型、制剂要求和作用机制。此外,它还描述了淋巴靶向在治疗中的靶向、类型、物理化学性质、生物屏障和益处。最后,介绍了 SMEDDS 制剂的市售制剂和未来方面。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验